GB202005448D0 - A stable and ready to administer liquid pharmaceutical composition of topiramate - Google Patents

A stable and ready to administer liquid pharmaceutical composition of topiramate

Info

Publication number
GB202005448D0
GB202005448D0 GBGB2005448.2A GB202005448A GB202005448D0 GB 202005448 D0 GB202005448 D0 GB 202005448D0 GB 202005448 A GB202005448 A GB 202005448A GB 202005448 D0 GB202005448 D0 GB 202005448D0
Authority
GB
United Kingdom
Prior art keywords
topiramate
ready
stable
pharmaceutical composition
liquid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2005448.2A
Other versions
GB2594242A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syri Ltd
Original Assignee
Syri Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syri Ltd filed Critical Syri Ltd
Priority to GB2005448.2A priority Critical patent/GB2594242A/en
Publication of GB202005448D0 publication Critical patent/GB202005448D0/en
Publication of GB2594242A publication Critical patent/GB2594242A/en
Pending legal-status Critical Current

Links

GB2005448.2A 2020-04-14 2020-04-14 A stable and ready to administer liquid pharmaceutical composition of topiramate Pending GB2594242A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2005448.2A GB2594242A (en) 2020-04-14 2020-04-14 A stable and ready to administer liquid pharmaceutical composition of topiramate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2005448.2A GB2594242A (en) 2020-04-14 2020-04-14 A stable and ready to administer liquid pharmaceutical composition of topiramate

Publications (2)

Publication Number Publication Date
GB202005448D0 true GB202005448D0 (en) 2020-05-27
GB2594242A GB2594242A (en) 2021-10-27

Family

ID=70848150

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2005448.2A Pending GB2594242A (en) 2020-04-14 2020-04-14 A stable and ready to administer liquid pharmaceutical composition of topiramate

Country Status (1)

Country Link
GB (1) GB2594242A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114053393A (en) * 2020-07-30 2022-02-18 广州朗圣药业有限公司 A pharmaceutical composition

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102022015798A2 (en) 2022-08-10 2024-02-20 Ems.S.A. LIQUID TOPIRAMATE COMPOSITION AND ITS USE, PROCESS FOR PREPARING A COMPOSITION AND KIT

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101257889A (en) * 2005-05-25 2008-09-03 詹森药业有限公司 Pediatric formulation of topiramate
GB2596184A (en) * 2018-09-13 2021-12-22 Ftf Pharma Private Ltd Non-aqueous solutions for oral dosage

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114053393A (en) * 2020-07-30 2022-02-18 广州朗圣药业有限公司 A pharmaceutical composition

Also Published As

Publication number Publication date
GB2594242A (en) 2021-10-27

Similar Documents

Publication Publication Date Title
GB202005448D0 (en) A stable and ready to administer liquid pharmaceutical composition of topiramate
PH12019501363A1 (en) Insulin containing pharmaceutical compositions
ZA202208676B (en) Use of pharmaceutical composition in preparing anti-viral drug
HRP20140592T1 (en) Improved medicinal compositions comprising buprenorphine and naltrexone
CL2011002807A1 (en) Compressible pharmaceutical mixture comprising crystals of a drug with a particle size of less than 40 um and a dissolution aid; A method of preparing a delivery vehicle for a drug that includes grinding a premix of drug crystals and a dissolution aid.
CY1112964T1 (en) KIT FOR PHARMACEUTICAL USE
MX2014008283A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof.
MA49023A (en) APPLICATION OF A COMPOUND OR AN EXTRACT OF TRADITIONAL CHINESE MEDICINE IN THE PREPARATION OF AN AGENT FOR THE ADMINISTRATION OF NUCLEIC ACID AND CORRESPONDING RELATED PRODUCTS
HRP20192189T1 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
EP4116302A4 (en) Compound and preparation method thereof and application thereof in preparation of therapeutic anti-cancer drug
HRP20140591T1 (en) Improved medicinal compositions comprising buprenorphine and nalmefene
ZA202207669B (en) Lipid composition and use thereof for delivery of a therapeutically active agent to endothelium
RU2011111792A (en) APPLICATION OF PARACETAMOL AND IBUPROFEN IN TREATMENT
ZA202104718B (en) Plant based ready to consume gel products with no added sugar and their use in delivery of agents
RU2017140078A (en) COSMETIC METHOD AND ITS THERAPEUTIC APPLICATION TO REDUCE THE FATTY OF FAT TISSUE
IL287912A (en) Pharmaceutical composition of a weak acid drug and methods of administration
MA54865A (en) CONCENTRATED LIQUID PHARMACEUTICAL FORMULATIONS OF FUROSEMIDE AND METHODS OF ADMINISTRATION THEREOF
EP4129280A4 (en) Use of thyroid hormone and analogue thereof in preparation of drugs for treating alpha-thalassemia
BR112015011982A8 (en) diacylglycerol acyltransferase inhibiting compounds, pharmaceutical composition comprising these and uses thereof
ZA202109873B (en) Application of pectolinarin in preparation of anti-osteosarcoma drugs
HUP2100370A1 (en) Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3
EP4059504A4 (en) Drug substance of lemborexant and medicinal composition comprising same
EP4106851A4 (en) Delivery of medication to a treatment site within a body
Wijaya Tatalaksana Nyeri Neuropatik Perifer dengan Sediaan Patch
EA201590323A1 (en) METHOD OF INTRODUCTION OF ACTIVE SUBSTANCES IN THE HEAD BRAIN